EMA Hopes to Approve Modified Corona Vaccines Before the Fall
The European Medicines Agency (EMA) hopes adapted corona vaccines will be available next autumn. In addition, various manufacturers are developing vaccines that work specifically against the omikron variant of the virus.
“Our priority is to have modified vaccines approved by September, if possible, to prepare for new vaccination campaigns in the EU in the fall,” said EMA director Marco Cavaleri on Thursday.
If the approval comes just after the summer, it will allow manufacturers to set production for the next round, Cavaleri explained. Pfizer/BioNTech and Moderna are the furthest with their vaccines adapted to the omikron variant, which made rapid advances after the turn of the year and has been dominant for months now. Clinical trials are underway to determine the safety and efficacy of their modified vaccines. It is still unknown whether one or two new shots will be needed.
The EMA also announced that it has started to assess whether Moderna’s corona vaccine can be given to children from six months of age. The American manufacturer was the first to submit a request to this effect to the European Union regulator. So far, corona vaccines have been approved in Europe for children from 5 years old.